Avenue Therapeutics, Inc. (ATXI)
OTCMKTS
· Delayed Price · Currency is USD
0.550
0.00 (0.00%)
Apr 29, 2026, 1:26 PM EST
Avenue Therapeutics Revenue
In the year 2025, Avenue Therapeutics had annual revenue of $1.40M.
Revenue
1.40M
Revenue Growth
n/a
P/S Ratio
1.29
Revenue / Employee
1.40M
Employees
1
Market Cap
1.81M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAvenue Therapeutics News
- 4 months ago - Avenue Therapeutics Transcript: AGM 2025 - Transcripts
- 1 year ago - Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 1 year ago - Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - GlobeNewsWire
- 1 year ago - Avenue Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 1 year ago - Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 years ago - Avenue Therapeutics Transcript: AGM 2024 - Transcripts
- 2 years ago - Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 2 years ago - Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) - GlobeNewsWire